Canbridge Pharmaceuticals

Ultragenyx

This biopharmaceutical company develops and commercialises therapies for patients with serious rare and ultra-rare genetic diseases.

GondolaBio

This biopharmaceutical company develops clinical-stage and preclinical medicinal therapeutics for patients living with rare genetic diseases.

LianBio

LianBio develops and commercialises biopharmaceutical products and medical technologies for patients with unmet clinical needs in China and other Asian markets.

Everest Medicines

This biopharmaceutical company develops and commercialises therapeutic products and vaccines to treat patients with unmet medical needs in Asia and global markets.

SpringWorks Therapeutics

This biopharmaceutical company develops and commercialises targeted oncology medicines and therapies for patients with rare diseases and cancer.

Krystal Biotech

This biotechnology company develops and commercialises redosable gene therapies for patients with rare genetic diseases, including dystrophic epidermolysis bullosa.

Kinnate Biopharma

The company develops small molecule kinase inhibitors for patients with difficult-to-treat cancers featuring specific genetic alterations.

Blueprint Medicines

This biopharmaceutical company develops and commercialises kinase inhibitors for patients with systemic mastocytosis, gastrointestinal stromal tumours and other genomic-driven cancers.